Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Muller

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomideQi Ding, Philip Kestell, Bruce C Baguley, et al.
Plos Pathogens|September 28, 2011
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
The American Journal of Pathology|June 28, 2011
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathologySelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Plos One|March 3, 2011
Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected miceMi-Sun Koo, Claudia Manca, Guibin Yang, et al.
The Journal of Clinical Investigation|December 8, 2007
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cellsLaure A Moutouh-de Parseval, Dominique Verhelle, Emilia Glezer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapyJoseph A Blansfield, Diana Caragacianu, H Richard Alexander, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2008
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cellsChristine Galustian, Brendan Meyer, Marie-Christine Labarthe, et al.
Microvascular Research|March 31, 2005
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitroKeith Dredge, Rebecca Horsfall, Simon P Robinson, et al.
Journal of Medicinal Chemistry|March 31, 2017
Protein Degradation via CRL4<sup>CRBN</sup> Ubiquitin Ligase: Discovery and Structure-Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1Joshua D Hansen, Kevin Condroski, Matthew Correa, et al.
Journal of Medicinal Chemistry|April 21, 2017
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and AiolosMary E Matyskiela, Weihong Zhang, Hon-Wah Man, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomideQi Ding, Philip Kestell, Bruce C Baguley, et al.
Plos Pathogens|September 28, 2011
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
The American Journal of Pathology|June 28, 2011
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathologySelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Plos One|March 3, 2011
Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected miceMi-Sun Koo, Claudia Manca, Guibin Yang, et al.
The Journal of Clinical Investigation|December 8, 2007
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cellsLaure A Moutouh-de Parseval, Dominique Verhelle, Emilia Glezer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapyJoseph A Blansfield, Diana Caragacianu, H Richard Alexander, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2008
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cellsChristine Galustian, Brendan Meyer, Marie-Christine Labarthe, et al.
Microvascular Research|March 31, 2005
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitroKeith Dredge, Rebecca Horsfall, Simon P Robinson, et al.
Journal of Medicinal Chemistry|March 31, 2017
Protein Degradation via CRL4<sup>CRBN</sup> Ubiquitin Ligase: Discovery and Structure-Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1Joshua D Hansen, Kevin Condroski, Matthew Correa, et al.
Journal of Medicinal Chemistry|April 21, 2017
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and AiolosMary E Matyskiela, Weihong Zhang, Hon-Wah Man, et al.
Pageof 3